Mursla Bio introduces AI precision medicine platform built on organ-specific EV isolation from blood
Platform is built on biologically labelled, organ-specific multi-omics data carried by extracellular vesicles isolated from 2ml plasma samples
Platform is built on biologically labelled, organ-specific multi-omics data carried by extracellular vesicles isolated from 2ml plasma samples
The DAWN is the premier Multi-Angle static Light Scattering (MALS) detector for absolute characterization of the molar mass and size of macromolecules and nanoparticles in solution, offering the highest sensitivity and widest range of molecular weight, size, concentration and optional features.
One lab shares its experience boosting efficiency and accuracy with StatLab’s PiSmart Cassette and Slide printers
T cell isolation and controlled release delivers flexibility and control in process development, clinical trials and commercial manufacturing
Immunoassay for the quantitative determination of IgG antibodies to the hepatitis E virus (HEV) in human serum and plasma
QuantiFERON-TB Gold Plus remains crucial for the detection of latent tuberculosis infection, aiding in breaking the cycle of disease transmission
The Selux PBC Separator, part of the Next Generation Phenotyping (NGP) System, makes this the only FDA cleared, single-platform technology capable of delivering rapid AST results for both positive blood culture and isolated colonies
David Wells, CEO of the IBMS, discusses the Institute’s plans to ensure the future of biomedical science careers
Company to share latest advances at pathology congress
Cologuard Plus was evaluated against an independent fecal immunochemical test, which it significantly outperformed
The partnership aims to deliver instruments, reagents, and consumables to service laboratories, breeders, and researchers worldwide.
The blood-based immunoassay test enables clinicians to identify the virus linked with COVID-19